Cipla’s arm enters into agreement to sell 99% stake in AJDMA

09 Jun 2017 Evaluate

Cipla’s subsidiary - Saba Investment has entered into an agreement to sell its entire 99% equity stake in Al Jabal for Drugs and Medical Appliances Company, Yemen (AJDMA) to Khalil Ghaleb Ali Al-Jabal. The company has entered into an agreement for sale on June 7, 2017 and the transaction is expected to be closed within 35 days from Effective Date.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.


Cipla Share Price

1341.50 -6.15 (-0.46%)
19-Apr-2024 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1512.65
Dr. Reddys Lab 5926.05
Cipla 1341.50
Zydus Lifesciences 931.30
Lupin 1576.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.